bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth [Yahoo! Finance]
bioAffinity Technologies, Inc. (BIAF)
Company Research
Source: Yahoo! Finance
SAN ANTONIO, April 24, 2024 BUSINESS WIRE bioAffinity Technologies , Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, today announced David Elzi, Ph.D., has been named Vice President of Product Development to accelerate the development of new diagnostics based on the proprietary technology platform behind CyPath® Lung , the Company's commercial test for the detection of early-stage lung cancer. "As commercialization of CyPath® Lung continues to meet or exceed our projections, new products that will improve patients' lives are an essential part of our growth strategy, which is focused on expanding our portfolio of solutions for detecting serious lung health issues at an early stage when treatment can positively impact prognosis," said bioAffinity Technologies President and CEO Maria Zannes. "Dr. Elzi has led our research team for eight years, helping to bring
Show less
Read more
Impact Snapshot
Event Time:
BIAF
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIAF alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIAF alerts
High impacting bioAffinity Technologies, Inc. news events
Weekly update
A roundup of the hottest topics
BIAF
News
- bioAffinity Technologies News UpdateBusiness Wire
- bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of GrowthBusiness Wire
- bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening [Yahoo! Finance]Yahoo! Finance
- bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer ScreeningBusiness Wire
- bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]Yahoo! Finance
BIAF
Sec Filings
- 4/24/24 - Form 4
- 4/24/24 - Form 4
- 4/24/24 - Form 4
- BIAF's page on the SEC website